Background. Limited information is available on the association between influenza vaccination and postoperative outcomes. Methods. Using Taiwan's National Health Insurance Research Database reimbursement claims data from 2008-2013, we conducted a matched cohort study of 16 903 patients aged >66 years who received influenza vaccinations and later underwent major surgery. Using a propensity score matching procedure adjusted for sociodemographic characteristics, medical condition, surgery type, and anesthesia type, 16 903 controls who underwent surgery but were not vaccinated were selected. Logistic regressions were used to calculate odds ratios (ORs) with 95% confidence intervals (CIs) for postoperative pneumonia and in-hospital mortality associated with influenza vaccination.
Influenza is a major cause of morbidity and mortality in older adults vulnerable to postinfluenza complications, particularly pneumonia [1] . This group experiences about 90 000 hospitalizations for influenza-related pneumonia and 44 000 influenza-linked deaths annually in the United States [2, 3] . In Europe, influenza-related hospitalizations among elderly persons ranged from 95 to 288 cases/100 000, whereas mortality ranged from 57 to 160 deaths/100 000 [4] .
Routine annual influenza vaccination for all persons aged >6 months was recommended by the Advisory Committee on Immunization Practices [5] . Although the World Health Organization and the European Union adopted a target for influenza vaccination coverage of 75% of older adults, this coverage remains suboptimal and has recently declined in Europe [6] . Doubts in the public about influenza vaccination safety and efficacy during a 2009 pandemic period contributed to this decline. Although influenza vaccination was controversial [7] [8] [9] , its association with reduced risks of pneumonia, hospitalization, and all-cause deaths among elderly persons was widely recognized [10] [11] [12] [13] [14] . Vaccination also reduced the number of primary care visits and hospitalizations, leading to cost savings [15] .
Pneumonia is a common postoperative complication, causing morbidity and mortality [16] [17] [18] . Various preventive strategies have been developed to reduce postoperative pulmonary complications, but few interventions have proven beneficial [16] . Whether influenza vaccination can decrease the risks of postoperative pneumonia and mortality in older adults had not been researched, so we conducted a nationwide population-based matched study to investigate this, using Taiwan's National Health Insurance Research Database.
METHODS AND MATERIALS

Source of Data
The National Health Insurance program in Taiwan was implemented in March 1995 and now covers >99% of Taiwan's 23 million residents. We conducted this study by using reimbursement claims data from the National Health Insurance Research Database that records all beneficiaries' medical services, including inpatient and outpatient demographic characteristics, physicians' primary and secondary diagnoses, treatment procedures, prescriptions, and medical expenditures. Scientific articles based on this database have been accepted for publication in prominent journals [17, 18] . This study was evaluated and approved by Taiwan's National Health Research Institutes and the Institutional Review Board of Taipei Medical University (protocols TMU-JIRB-201506001, TMU-JIRB-201505055, and TMU-JIRB-201404070).
Study Design
Among the >3 million Taiwan residents who underwent major inpatient surgeries (defined as procedures requiring general, epidural, or spinal anesthesia, as well as hospitalization for >1 day) in 2008-2013, we examined medical claims and identified 899 520 people aged ≥66 years. Of these, 881 300 had received influenza vaccination in the year before the index surgery. Each patient who underwent surgery and received influenza vaccination was randomly matched to an unvaccinated patient who underwent surgery, using a propensity score matched-pair procedure to adjust for age, sex, low-income status, hospital volume, coexisting medical conditions, and surgery and anesthesia types. After propensity score matching (case-control ratio, 1:1), there were 16 903 patients with and 16 903 without preoperative influenza vaccination.
Measures and Definitions
In this study, low-income status was defined as having a low income within 2 years before surgery. According to the regulations from the Bureau of National Health Insurance in Taiwan, people with low-income status were qualified to have the registration fee and medical copayment waived when visiting outpatient, emergency, and inpatient medical care. The criterion of low income was defined by local city or county governments. For example, a person living in Taipei (the capital of Taiwan) with a monthly income of less than US$500 (1 Taiwanese dollar is equal to US$30.324) and immovable possessions with a value of less than US$24 4031 per household was considered to have a low income. In Taiwan, there were 146 379 low-income households and 342 490 low-income people in 2015. The definition of low income varies with urban and rural areas because of the local living conditions. The hospital volume was categorized into 3 groups: low, moderate, and high. The International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) was used to define physicians' diagnoses. Based on our previous studies [17, 18] , preoperative medical conditions determined from medical claims for the 24-month preoperative period included hypertension (ICD-9-CM 401-405), diabetes (ICD-9-CM 250), mental disorders (ICD-9-CM 290-319), cancer (ICD-9-CM 140-208, 230-234), chronic obstructive pulmonary disease (ICD-9-CM 491,492, 496), ischemic heart disease (ICD-9-CM 410-414), atherosclerosis (ICD-9-CM 440), heart failure (ICD-9-CM 428), stroke (ICD-9-CM 430-438), Parkinson disease (ICD-9-CM 332), and liver cirrhosis (ICD-9-CM 571.2, 571.5, 571.6). Renal dialysis was defined by administration codes (D8 and D9). Postoperative pneumonia (ICD-9-CM 480-486) and in-hospital mortality after the index surgery were considered the study's primary outcomes. Admission to the intensive care unit, length of hospital stay, and medical expenditures after the index surgery were also compared between patients with and those without preoperative influenza vaccination.
Statistical Analyses
We used propensity score-matched pair analysis to determine associations between influenza vaccination and postoperative outcomes. A non-parsimonious multivariable logistic regression model was used to estimate a propensity score for surgical patients receiving influenza vaccination or not. Clinical significance guided the initial choice of covariates in this model to include age, sex, low income, hospital volume, types of surgery and anesthesia, hypertension, diabetes, mental disorders, cancer, chronic obstructive pulmonary disease, ischemic heart disease, atherosclerosis, heart failure, stroke, Parkinson disease, liver cirrhosis, and renal dialysis. We matched influenza vaccine recipients to nonrecipients, using a greedy matching algorithm (without replacement) with a caliper width of 0.2 SDs of the log odds of the estimated propensity score. Categorical variables are summarized using frequencies (percentages) and were compared between influenza vaccine recipients and nonrecipients by using χ 2 tests. Continuous variables are summarized using means ± standard deviations and were compared using t tests. Logistic regressions were used to calculate the adjusted odds ratios (ORs) and 95% confidence intervals (CIs) of postoperative outcomes associated with influenza vaccination. Additional analyses stratified by age, sex, number of medical conditions, and surgery type were also performed, to examine outcomes after surgery among influenza vaccine recipients within these strata.
RESULTS
The baseline characteristics of influenza vaccine recipients and nonrecipients who underwent major surgeries are shown in Table 1 . Under the propensity score matching procedure, there were no significant differences in age, sex, low-income status, hospital volume, surgery or anesthesia types, hypertension, diabetes, mental disorders, cancer, chronic obstructive pulmonary disease, ischemic heart disease, atherosclerosis, heart failure, stroke, Parkinson disease, liver cirrhosis, or renal dialysis between patients with and those without preoperative influenza vaccination.
Compared with controls (Table 2) , patients with influenza vaccination had lower risks of postoperative pneumonia (OR, 0.60; 95% CI, .56-.64), intensive care unit admission (OR, 0.56; 95% CI, .53-.60), and in-hospital mortality (OR, 0.46; 95% CI, .38-.55). Length of hospital stay (mean ± SD, 10.30 ± 12.22 days vs 12.87 ± 28.83 days; P < .0001) and medical expenditure (mean ± SD, US$3692 ± US$4276 vs US$4235 ± US$5309; P < .0001) were also lower in patients with as compared to those without influenza vaccination.
In Table 3 , the stratification analysis shows that influenza vaccination was associated with reduced postoperative pneumonia among men (OR, 0.61; 95% CI, .56-. a Sensitivity analysis performed after excluding patients with influenza vaccination ≤14 days before surgery revealed that the OR for the association between influenza vaccination and postoperative pneumonia was 0.60 (95% CI, .56-.64).
b Adjusted for all covariates listed in Table 1 . (Table 5) , those with influenza vaccination 10-12 months before surgery had the lowest risk of postoperative pneumonia (OR, 0.60; 95% CI, .56-.64) and mortality (OR, 0.46; 95% CI, .38-.55). For the vaccinated population, the additional influenza vaccination 13-24 months before surgery was associated with postoperative pneumonia (OR, 0.55; 95% CI, .54-.62) and mortality (OR, 0.46; 95% CI, .38-.55). Preoperative adult health examination and breast examination were also associated with a reduced risk of postoperative pneumonia (OR, 0.47; 95% CI, .30-.73) and mortality (OR, 0.40; 95% CI, .10-1.64).
DISCUSSION
In this nationwide, population-based matched cohort across 6 influenza seasons, we found that preoperative influenza vaccination was associated with reductions in postoperative pneumonia, intensive care admission, length of hospital stay, medical expenditures, and in-hospital mortality after elderly patients underwent major surgeries. The beneficial effects of influenza vaccination were further validated by stratification analyses examining sex, age, economic status, hospital volume, and various comorbidities but not those examining patients with >2 medical conditions. To the best of our knowledge, this is the first study demonstrating the beneficial effects of preoperative influenza vaccination on the risks of postoperative pneumonia and mortality in elderly populations for whom surgery was performed.
In previous studies, age, socioeconomic status, and level of hospital were not only independent risk factors associated with perioperative adverse outcomes but also affected populations that did nor did not receiving influenza vaccination [16, [19] [20] [21] [22] . In addition, hypertension, diabetes, cardiovascular and pulmonary disease, stroke, and mental disorders were common medical conditions affecting elderly influenza vaccine recipients and were associated with postoperative morbidities and mortality [17, 18, [21] [22] [23] [24] [25] [26] . Postoperative complications were also influenced by surgery and anesthesia types [27, 28] . To avoid bias when investigating the relationships between influenza vaccination and postoperative pneumonia and mortality, we used multivariate regression models to adjust for these potential confounding factors and showed that patients with preoperative influenza vaccination had lower risks of postoperative pneumonia and in-hospital mortality. a Sensitivity analysis performed after excluding patients with influenza vaccination ≤14 days before surgery revealed that the OR for the association between influenza vaccination and postoperative 30-day mortality was 0.46 (95% CI, .38-.55).
b Adjusted for all covariates listed in Table 1 . The effectiveness of influenza vaccination among community-dwelling older adults has been demonstrated by reductions in pneumonia admission and all-cause mortality [10] [11] [12] [13] [14] . A case-control study showed that influenza vaccination prevented 61% of expected influenza-associated hospitalizations in adults aged >49 years [10] . Influenza vaccination was associated with significantly decreased risks of pneumonia and death among community-dwelling elderly persons, and well-matched vaccines reduced pneumonia, hospitalizations, and all-cause mortality in older adults [11] [12] [13] [14] . However, the effect of influenza vaccination on the outcomes of patients who underwent surgery was unknown. Influenza can spread rapidly in hospitals among weakened older patients in renal, transplant, oncology, and long-term care units [29] . Although influenza vaccination has been recommended for hospitalized persons when vaccine is available [5] , nosocomial influenza virus infection among hospitalized populations remains as high as 20% [30] , particularly in elderly patients admitted to hospitals for surgery, and vaccination of surgical inpatients against influenza was recommended [5, 31] . Influenza vaccination before hospitalization has been shown to reduce mortality and readmission rates following discharge in elderly patients admitted with pneumonia [32, 33] . Our study showed these protective effects of influenza vaccination extending to outcomes after major surgeries.
The stratification analysis showed that the protective effect of influenza vaccination against postoperative in-hospital mortality decreased with age and complexity of medical conditions. Similar results were observed in influenza vaccination's efficacy in reducing postoperative pneumonia.
Influenza vaccine has been shown to reduce the risk of hospitalizations for heart disease, cerebrovascular disease, all-cause pneumonia, influenza, and all-cause mortality [11] [12] [13] [14] 34] . The reduced risk of cardiovascular events conferred by influenza vaccination have also been investigated [35, 36] . Undoubtedly, influenza virus infection causes exacerbations of coexisting diseases, particularly in fragile patients who underwent surgery. In addition, high rates of nosocomial influenza and pneumonia were reported in hospitalized patients [37, 38] . Thus, it is reasonable that we observed a reduced risk of postoperative pneumonia and mortality among influenza vaccine recipients.
Two reasons may explain these phenomena. First, antibody responses to influenza vaccination, such as seroconversion and seroprotection, are known to decrease with increasing age, especially in subjects aged ≥75 years; these might be unable to induce an effective protective response in older patients [39] . Second, reduced protective effects of influenza vaccination in patients with >2 medical conditions may relate to these patients' higher risk of postoperative mortality [23] [24] [25] . A poor immune response to influenza vaccination was also observed in patients with chronic diseases, and the benefits of influenza vaccination were noted to be lower for high-risk older adult subjects than the low-risk group [11, [40] [41] [42] . Our study showed that patients with ≥3 medical conditions were less protected by influenza vaccination from all-cause mortality. These critically ill patients might die of various perioperative complications before developing influenza or pneumonia.
Strengths of the present study include its large sample size, inclusion of 6 influenza season-years (2008-2013), and adjustment for various potential confounding factors. It also has a Data are for patients with preoperative influenza vaccinations within 1 year who also had additional influenza vaccinations in the 13-24 months preoperatively.
several limitations: First, different serotypes of influenza vaccine for each year might provide different levels of protection. Although it is impossible to standardize vaccine types for the study, we used the stated vaccine type for each year. Second, the National Health Insurance Research Database lacked detailed information on sociodemographic and lifestyle factors, such as tobacco or alcohol consumption, so potential confounders, such as functional status or smoking habits, could not be obtained. Third, the diagnoses relied on ICD-9-CM coding in the database. It is also a limitation that unavailable ICD-10-CM codes hindered us from analyzing detailed information of influenza vaccination. Patients with chronic diseases may not have sought medical services for these during the study period, and some coexisting medical conditions might be underestimated.
However, this possible underestimation should be equally distributed between both groups, minimizing any bias. Fourth, while we have adjusted for various confounders, residual confounding could not be excluded, which may have led to underestimation of the benefits of influenza vaccination. In addition, owing to the time-related limitations of our database, we could not obtain longer-term data on the history of medical procedures. Finally, misclassification of vaccination status may have occurred, with incomplete recording of receipt of vaccine leading to vaccinated patients being classified as unvaccinated. Yet if such misclassifications occurred, this would likely have biased the study results toward the null hypothesis.
In conclusion, we found that geriatric patients who underwent surgery and received preoperative influenza vaccination were protected from postoperative pneumonia and in-hospital mortality after major surgery, compared with patients who did not receive influenza vaccine before surgery. These findings should be followed by randomized trials to further evaluate influenza vaccination's effects on perioperative outcomes.
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